Ind-Swift Laboratories share news and announcements
NSE: INDSWFTLABBSE: 532305Pharmaceuticals & BiotechnologySmall Cap
Last close ₹327.45down ₹17.90 (5.18%)BSE ₹327.80
Share price at the NSE close on 23 Oct 2026. Previous close ₹345.35.
52-week range of traded prices to 23 Oct 2026
₹87.15Low, 31 Dec 2025₹424.75High, 30 Sep 2026
- Under NSE's long-term additional surveillance, stage I, on the list for 23 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Next results date: the board meets on 29 Oct 2026 to consider: financial results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹2,848 Cr1,404th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 10 Aug 2026
- 49.7
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹11 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 41.5
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 28 May 2026
- 2.1
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 10 Aug 2026
- 4.5%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹11 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 5.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 10 Aug 2026
- 2.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 28 May 2026
- 0.01
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 6,58,24852.8% delivered
Ind-Swift Laboratories share news and announcements
907 announcements, routine notices left out, newest first. Page 17 of 19.
May 2011
26 May · Dividend
Board of Directors of the Company at its meeting held on May 25, 2011, has recommended a dividend of Rs.1/- per share on Equity Shares of Rs.10/- each the Company.11 May · Board meeting
To transact inter-alia among other items the following business : (1) To adopt Annual Audited Accounts for the financial year ended March 31, 2011; (2) To consider declaration of dividend, if any, approved by the Board on the equity shares of the Company; (3) Allotment of Shares under Employee Stock Option Plans (ESOP).
Apr 2011
19 Apr · Results
Company has decided to adopt the audited financial results for the year 2010-11 within 60 days of the closure of the last quarter instead of adopting unaudited quarterly results for the quarter ended March 31, 2011.
Mar 2011
28 Mar · Board meeting
Board of Directors have in its meeting held today i.e. 28th March, 2011 approved the allotment of 16,00,000 equity shares as under:(1) 7,00,000 equity shares allotted to Promoters Group upon conversion of 7,00,000 Zero Coupon Optionally Convertible Warrants (2010 Series) at a price of Rs.82.50/- per share. (2) 9,00,000 equity shares allotted to Other Bodies Corporate upon conversion of 9,00,000 Zero Coupon Optionally Convertible Warrants (2010 Series) at a price of Rs.82.50/- per share.22 Mar · Board meeting
To consider and approve inter-alia among other items, allotment of equity shares upon conversion of another tranche of warrants into equity shares.15 Mar · Business
Board of Directors have in its meeting held on March 15, 2011 approved the allotment of 21,20,000 equity shares as under: 1) 5,35,000 equity shares allotted to Promoters Group upon conversion of 535000 Zero Coupon Optionally Convertible Warrants (2009 Series) at a price of Rs. 50/- per share. 2) 4,85,000 equity shares allotted to Promoters Group upon conversion of 4,85,000 Zero Coupon Optionally Convertible Warrants (2010 Series) at a price of Rs. 82.50/- per share. 3) 11,00,000 equity shares allotted to Other Bodies Corporate upon conversion of 11,00,000 Zero Coupon Optionally Convertible Warrants (2010 Series) at a price of Rs. 82.50/- per share.10 Mar · Board meeting
To consider and approve inter-alia among other items, allotment of equity shares upon conversion of warrants into equity shares.3 Mar · Limited Review Report
Auditors have conducted the limited review for the un-audited financial results for the quarter ended December 31,2010. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Feb 2011
Jan 2011
31 Jan · Business
Board of Directors of the Company have, in its meeting held on January 29, 2011, allotted 10,00,000 equity shares of Rs.10/- each at a premium of Rs.40/- per shares to Promoters Group upon the conversion of 10,00,000 Zero Coupon Optionally Convertible Warrants (2009 Series).19 Jan · Board meeting
To transact inter-alia among other items the following business : (1) Quarterly Unaudited Financial Results (Provisional) for the Quarter ended December 31, 2010; (2) To consider & approve allotment of equity shares upon conversion of warrants (Series 2009) into equity shares.
Nov 2010
22 Nov · Limited Review Report
Auditors have conducted the limited review for the un-audited financial results for the quarter ended September 30,2010. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.15 Nov · Business
Board of Directors of the Company at its meeting held on November 13, 2010, approved the Allotment of 1,85,660 Shares to employees under Employee Stock Option Plan (ESOP).
Oct 2010
27 Oct · Board meeting
Company had informed the Exchange regarding the meeting of the Board of Directors of the Company scheduled to be held on November 08, 2010 To consider inter-alia among other items, the Quarterly Unaudited Financial Results (Provisional) for the quarter ended September 30, 2010. The Company has now informed the Exchange that the Board Meeting of the Company is scheduled to be held on November 13, 2010 to consider inter-alia among other items, the Quarterly Unaudited Financial Results (Provisional) for the quarter ended September 30, 2010.Not held on this date
26 Oct · Board meeting
To consider inter-alia among other items, the Quarterly Unaudited Financial Results (Provisional) for the quarter ended September 30, 2010.21 Oct · Business
Board of Directors of the Company in its meeting held on October 21, 2010, allotted 80,00,000 Zero Coupon Optionally Convertible Warrants (Series 2010) to Promoters Group Companies and other Bodies Corporate at a price of Rs. 82.50/- per warrant.20 Oct · Board meeting
To consider and approve allotment of 80,00,000 Zero Coupon Convertible Warrants (2010 Series) to Promoter Group Companies and other Bodies Corporate.7 Oct · Board Meeting Deferred
Board of Directors meeting scheduled to be held on October 06, 2010 for allotment Zero Coupon Convertible warrants (Series 2010) on preferential basis to Promoters Group Companies and other body Corporate has been postponed and will be held upon the receipt of necessary approvals from the Stock Exchanges.1 Oct · Management
Board of Directors have appointed Dr. N.P. Singh as Independent Director with immediate effect.1 Oct · Board meeting
To consider and approve allotment of 80,00,000 Zero Coupon Convertible Warrants (2010 Series) to Promoter Group Companies and other Bodies Corporate.
Sep 2010
Aug 2010
26 Aug · Meeting
Register of Members of the Company shall remain closed from September 20, 2010 to September 22, 2010 (both days inclusive) for the purpose of Annual General Meeting and payment of Dividend. Further, the Company has informed that the Annual General Meeting of the shareholders of the Company is scheduled to be held on September 22, 2010.26 Aug · Board meeting
Board of Directors of the Company at its Meeting held on August 25, 2010 approved inter-alia the following : (1) Increase in Authorized Share Capital of the Company from Rs. 35 Crores to Rs. 60 Crores; (2) To raise funds upto Rs. 500 crores through GDR/FCCB/QIP or any other route; (3) Issue of 80,00,000 Zero Coupon optionally Convertible Warrants to Promoters & other Bodies Corporate as per SEBI (ICDR) Guidelines;20 Aug · Board meeting
Inter-alia among other items the following matter: 1) To fixation of the date of Annual General Meeting and other related items. 2) Fresh preferential Issue of Convertible warrants to Promoters Group.
Jul 2010
12 Jul · Board meeting
To consider inter-alia among other items, the Quarterly Unaudited Financial Results (Provisional) for the quarter ended June 30, 2010.
May 2010
29 May · Dividend
Board of Directors of the Company at its meeting held on May 29, 2010, has recommended Dividend of Re. 1/- per share of Rs. 10/- each.6 May · Board meeting
To transact inter-alia among other items the following business : (1) To adopt Annual Audited Accounts for the financial year ended March 31, 2010; (2) To consider declaration of dividend, if any, approved by the Board on equity shares of the Company; (3) To consider & approve allotment of equity shares upon conversion of warrants (Series 2009) into equity shares.
Apr 2010
29 Apr · Results
The Company has decided to adopt the audited financial results for the year 2009-10 within 60 days of the closure of the last quarter instead of adopting unaudited quarterly results for the quarter ended March 31, 2010.
Mar 2010
23 Mar · Management
Ind-Swift Laboratories Ltd. has informed the Exchange that the Board of Directors of the Company met on March 23, 2010, the board have approved the following:(1) Appointment of Sh. N. R. Munjal as the Vice Chairman cum Managing Director of the Company, (2) Appointment of Sh. Himanshu Jain, Director as the Joint Managing Director of the Company, (3) Appointment of Mr. Rishav Mehta S/o Late Sh. V. K. Mehta as the Director of the Company, (4) Appointment of Sh. Pradeep Kumar as an Independent Director on the Board of the Company, (5) Appointment of Dr. L. K. Wadhwa as the Chief Operating Officer (COO). The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.22 Mar · Board meeting
To appoint the new Managing Director of the Company.22 Mar · Demise of Director
Ind-Swift Laboratories Ltd. has informed the Exchange regarding the untimely and sudden demise of the Managing Director of the Company Sh.V.K.Mehta on March 21, 2010.
Feb 2010
25 Feb · Limited Review Report
Ind-Swift Laboratories Ltd. has informed the Exchange that the auditors have conducted the limited review for the un-audited financial results for the quarter ended December 31,2009 A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jan 2010
15 Jan · Board meeting
To consider inter-alia among other items, the Quarterly Unaudited Financial Results (Provisional) for the quarter ended December 31, 2009.
Dec 2009
14 Dec · Board meeting
Ind-Swift Laboratories Ltd. has informed the Exchange that "The Board of Directors have in its meeting held today i.e. 12th December, 2009 approved the following: (1) Allotment of 30,00,000 Zero Coupon Convertible Warrants (2009 Series) to Promoter Group Company at a price of Rs.50/- per warrant. (2) Allotment of 142460 Shares to employees under Employee Stock Option Plan (ESOP). (3) Resignation of Dr. S.D. Nanda, Director from the Directorship of the Company".10 Dec · Board meeting
To transact inter-alia among other items the following business: (1) To consider and approve Allotment of 30,00,000 Zero Coupon Convertible Warrants (2009 Series) to Promoter Group Company. (2) Allotment of Shares under Employee Stock Option Plan (ESOP).4 Dec · Limited Review/Others
Ind-Swift Laboratories Ltd. has informed the Exchange that the auditors have conducted the limited review for the un-audited financial results for the quarter ended September 30,2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Oct 2009
24 Oct · Meeting
Ind-Swift Laboratories Ltd. has submitted to the Exchange a copy of the minutes of the proceedings of Annual General Meeting of the members of the Company held on September 24, 2009. The copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.15 Oct · Board meeting
To consider inter-alia among other items, the Quarterly Unaudited Financial Results (Provisional) for the second quarter ended September 30, 2009.6 Oct · Board meeting
To consider and approve allotment of 30,00,000 Zero Coupon Convertible Warrants (2009 Series) to Promoter Group Company.
Sep 2009
24 Sep · Meeting
Ind-Swift Laboratories Ltd. has informed the Exchange that shareholders of the Company in its Annual General Meeting held on September 24, 2009 have approved the following: 1) To Increase in remuneration of Sh. N.R. Munjal, Vice-Chairman and Sh. V.K. Mehta, Managing Director of the Company. 2) Increase in Borrowing Powers of the Company. 3) To issue upto 30,00,000 Zero Coupon Optionally Convertible Warrants to Promoters.3 Sep · Limited Review Report
Ind-Swift Laboratories Ltd. has informed the Exchange that the auditors have conducted the limited review for the un-audited financial results for the quarter ended June 30,2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.1 Sep · Meeting
Ind-Swift Laboratories Ltd. has informed the Exchange regarding the following decisions taken by the Board in its Meeting held on August 31, 2009: 1) The Board has fixed the date of closure of Register of Members from September 21, 2009 to September 23, 2009 (both days inclusive) for the purpose of payment of Dividend and Annual General Meeting which is scheduled to be held on September 24, 2009. 2) The Board has approved the appointment of Sh. S.P. Sharma (Vice President, IFCI Ltd.) as Nominee Director on the Board of the Company and accepted the resignation of Mrs. Nirmal Aggarwal. 33) The Board considered & approved fresh Preferential Issue of 30,00,000 convertible warrants to Promoters Group.
Aug 2009
31 Aug · Allotment of shares
Ind-Swift Laboratories Ltd. has informed the Exchange vide its letter dated August 29, 2009 that "The Board of Directors of the Company have in its meeting held on today i.e. August 29, 2009 allotted 6,37,000 equity shares of Rs.10/- each at a premium of Rs.60/- per shares to Promoters Group upon the conversion of 6,37,000 Zero Coupon Optionally Convertible Warrants (SERIES 2008)."